31st Jul 2007 09:22
Akers Biosciences, Inc.31 July 2007 Akers Biosciences, Inc. ("ABI" or the "Company") Total Voting Rights In conformity with the Transparency Directive's transitional provision 6, wewould like to notify the market of the following: As at 31st July 2007, the issued share capital and voting rights of the Companyconsists of 64,040,758 ordinary shares, nil par value, with voting rightsattached, one vote per ordinary share. The above total voting rights figure may be used by shareholders as thedenominator for the calculations by which they will determine whether they arerequired to notify their interests in, or a change to their interest in, ABIunder the FSA's Disclosure and Transparency Rules. Contact; Thomas A. Nicolette - President and CFO 001 856 848 2116 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
AKR.L